Sjoerd Servaas

Sjoerd Servaas

Auto-generated profile, based on publicly available information

Sjoerd Servaas

Department of Anaesthesia, Spaarne Gasthuis Academy, Hoofddorp, The Netherlands

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 June 2019 in Journal of Clinical Monitoring and Computing
Verified
Journal Article
Open access
PDF file
MSM. Sanders
M. Sanders
SSS. Servaas
S. Servaas
CSC. Slagt
C. Slagt
Cardiac output monitoring is used in critically ill and high-risk surgical patients. Intermittent pulmonary artery thermodilution and transpulmonary thermodilution, considered the gold standard, are invasive and linked to complications. Therefore, many non-invasive cardiac output devices have been developed and studied. One of those is electrical cardiometry. The results of validation studies are conflicting, which emphasize the need for definitive validation of accuracy and precision. We performed a database search of PubMed, Embase, Web of Science and the Cochrane Library of Clinical Trials to identify studies comparing cardiac output measurement by electrical cardiometry and a reference method. Pooled bias, limits of agreement (LoA) and mean percentage error (MPE) were calculated using a random-effects model. A pooled MPE of less than 30% was considered clinically acceptable. A total of 13 studies in adults (620 patients) and 11 studies in pediatrics (603 patients) were included. For adults, pooled bias was 0.03 L min−1 [95% CI − 0.23; 0.29], LoA − 2.78 to 2.84 L min−1 and MPE 48.0%. For pediatrics, pooled bias was − 0.02 L min−1 [95% CI − 0.09; 0.05], LoA − 1.22 to 1.18 L min−1 and MPE 42.0%. Inter-study heterogeneity was high for both adults (I2 = 93%, p < 0.0001) and pediatrics (I2 = 86%, p < 0.0001). Despite the low bias for both adults and pediatrics, the MPE was not clinically acceptable. Electrical cardiometry cannot replace thermodilution and transthoracic echocardiography for the measurement of absolute cardiac output values. Future research should explore it’s clinical use and indications.

8 July 2025 in British Journal of Anaesthesia
Verified
Journal Article
Open access
KBKaren E. Brokke
Karen E. Brokke
MGManon Graman
Manon Graman
SSSjoerd Servaas
Sjoerd Servaas
ISInger N. Sierevelt
Inger N. Sierevelt
MSMonique A.H. Steegers
Monique A.H. Steegers
PNPeter A. Nolte
Peter A. Nolte
Bone cement implantation syndrome comprises the occurrence of hypoxaemia, hypotension, unexpected loss of consciousness, or cardiac arrest occurring around the time of cementation, prosthesis insertion, or reduction of the joint in arthroplasty. As the yearly number of arthroplasties will increase, the number of complications including bone cement implantation syndrome is also expected to increase. Therefore, a good understanding of this syndrome is important. This scoping review aims to provide a comprehensive overview of the current knowledge of bone cement implantation syndrome. This scoping review was conducted based on the PRISMA-ScR Checklist. A literature search was done in PubMed, Cochrane, and Embase. A total of 85 studies were included in the study. The incidence of bone cement implantation syndrome during cemented hip or knee arthroplasty varied from 15.4% to 46.7% and 27.5% to 70.7%, respectively. The incidence in shoulder arthroplasty was 16.2%. In uncemented hip arthroplasty, the incidence ranged from 0.0% to 21.8%. Risk factors identified for bone cement implantation syndrome included advanced age, ASA physical status 3 or 4, and primary lung cancer or lung metastasis. Bone cement implantation syndrome is a potentially severe complication that can occur during both cemented and uncemented arthroplasty. Moreover, the occurrence of bone cement implantation syndrome is not dependent on the use of cement. However, the severity does seem to have an association with the fixation method.

4 April 2023 in Clinical Chemistry and Laboratory Medicine (CCLM)
Verified
Journal Article
Open access
PDF file
SSSjoerd Servaas
Sjoerd Servaas
SVSilke de Vreede
Silke de Vreede
RSRuben Smeets
Ruben Smeets
ASAn Stroobants
An Stroobants
LELucas T van Eijk
Lucas T van Eijk
CSCornelis Slagt
Cornelis Slagt
Objectives: The TensorTip™ MTX is a non-invasive device designed to determine several physiological parameters with additional analysis of haemoglobin, haematocrit and blood gas analysis by interpreting blood diffusion colour of the finger skin based on spectral analysis. The aim of our study was to investigate the accuracy and precision of the TensorTip MTX in a clinical setting in comparison with routine analysis of blood samples. Methods: Forty-six patients, scheduled for elective surgery, were enrolled in this study. Placement of an arterial catheter had to be part of the standard of care. Measurements were performed during the perioperative period. The measurements obtained with the TensorTip MTX were compared with the results of routine analysis of the blood samples as a reference using correlation, Bland-Altman analysis and mountain plots. Results: No significant correlation was present in the measurements. Measurement of haemoglobin with the TensorTip MTX had a mean bias of 0.4 mmol/L, haematocrit’s bias was 3.0 %. Bias of partial pressure of carbon dioxide and oxygen was 3.6 and 66.6 mmHg, respectively. Calculated percentage errors were 48.2 , 48.9, 39.9 and 109.0 %. Proportional bias was present in all Bland-Altman analyses. Less than 95 % of the differences fell within the pre-set limits of allowable error. Conclusions: Non-invasive blood content analysis with the TensorTip MTX device is not equivalent to and did not correlate sufficiently with conventional laboratory analysis. None of the parameters measured showed results within the limits of allowable error. Therefore, the use of the TensorTip MTX is not recommended for perioperative care.

1 December 2022 in Cardiology Research
Verified
Journal Article
Open access
PDF file
SSSjoerd Servaas
Sjoerd Servaas
LELucas T van Eijk
Lucas T van Eijk
SVSilke de Vreede
Silke de Vreede
IMIgnacio Malagon
Ignacio Malagon
CSCornelis Slagt
Cornelis Slagt
Background: The noninvasive TensorTip™ MTX measures blood pressure by interpreting blood diffusion color of the finger skin. In addition to blood pressure, the device is able to measure various vital signs: heart rate, oxygen saturation, stroke volume, and cardiac output. Studies about accuracy and precision thus far available have only been conducted by the manufacturer. The aim of our study was to investigate the accuracy and precision of the TensorTip MTX in comparison to invasive radial artery blood pressure values. Methods: Forty-one patients scheduled for elective surgery were enrolled in this study. Placement of the arterial catheter had to be part of the standard of care. Once hemodynamic stable conditions were achieved, blood pressure was measured. Three measurements with the TensorTip MTX were averaged and compared with one invasive blood pressure measurement using Bland-Altman plot and error grid analysis. Results: Systolic, diastolic, and mean blood pressure had a bias of respectively 6.2, -6.9 and 4.4 mm Hg. Corresponding standard deviation were respectively 30.1, 17.0 and 22.2. Calculated percentage errors were 47.6%, 52.9% and 52.3%. Proportional bias was present in all Bland-Altman analyses. Error grid analysis showed 61.0% of systolic blood pressure measurements, and 46.3% of mean blood pressure measurements were in the clinical acceptable zone. Conclusions: The TensorTip MTX was not able to reliably measure blood pressure compared to blood pressure obtained with an arterial catheter and therefore, the measurement performance is not clinically acceptable. Moreover, a high malfunction rate makes the device unsuitable for use in perioperative period. Cardiol Res. 2022;13(6):372-379 doi: https://doi.org/10.14740/cr1438

1 July 2022 in European Journal of Anaesthesiology
Verified
Journal Article
Closed access
SSSjoerd Servaas
Sjoerd Servaas
LELucas T. van Eijk
Lucas T. van Eijk
IMIgnacio Malagon
Ignacio Malagon
CSCornelis Slagt
Cornelis Slagt

1 July 2026 in JBJS Open Access
Verified
Journal Article
Open access
KBKaren E. Brokke
Karen E. Brokke
SSSjoerd Servaas
Sjoerd Servaas
ISInger N. Sierevelt
Inger N. Sierevelt
KKKarel W.J. Klop
Karel W.J. Klop
SBSef J.A. van Bilsen
Sef J.A. van Bilsen
PNPeter A. Nolte
Peter A. Nolte
Background: Cardiac arrest during hip or knee arthroplasty (KA) represents the most severe manifestation of bone cement implantation syndrome (BCIS). However, true incidence rates remain uncertain, and data on clinical characteristics and outcomes are limited. The aim of this study was to determine the incidence of BCIS grade 3 in hip and KA and to describe associated clinical characteristics and mortality. Methods: This retrospective multicenter case series included all hip and KA procedures performed at 4 Dutch hospitals. Potential cases were identified through database queries. Medical records were manually reviewed to confirm BCIS grade 3, defined as cardiovascular collapse requiring cardiopulmonary resuscitation occurring from joint manipulation through skin closure. Results: No cases of BCIS grade 3 occurred during 25,914 knee arthroplasties. Among 39,237 hip procedures, 31 patients experienced BCIS grade 3 (0.08%), of which 27 cases occurred during hemiarthroplasty for femoral neck fracture (FNF). The mean age of patients with BCIS grade 3 was 86.2 ± 7.7 years; 71.0% were female, 93.5% underwent acute surgery for FNF, 87.1% involved cemented procedures, and perioperative mortality was 67.7%. Conclusion: BCIS grade 3 is rare but highly lethal, occurring predominantly during hemiarthroplasty for FNF in elderly patients. Individualized risk assessment and informed consent are essential when managing FNF in high-risk patients. Level of Evidence: Prognostic Level IV . See Instructions for Authors for a complete description of levels of evidence.